Halberd Corp
OTC:HALB

Watchlist Manager
Halberd Corp Logo
Halberd Corp
OTC:HALB
Watchlist
Price: 0.001 USD -9.09% Market Closed
Market Cap: $635.9k

Profitability Summary

Halberd Corp's profitability score is 51/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

51 / 100
Profitability
Score
51 / 100
Profitability
Score

Margins

Earnings Waterfall
Halberd Corp

Margins Comparison
Halberd Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Halberd Corp
OTC:HALB
635.9k USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
183.3B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.7B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.3B USD
Loading...
Loading...
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
298.3B CNY
Loading...
Loading...
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
24.7B USD
Loading...
Loading...
Loading...
DE
BioNTech SE
NASDAQ:BNTX
22.5B USD
Loading...
Loading...
Loading...
BM
Roivant Sciences Ltd
NASDAQ:ROIV
19.7B USD
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
19.7B USD
Loading...
Loading...
Loading...
US
Incyte Corp
NASDAQ:INCY
18.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Halberd Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Halberd Corp
OTC:HALB
635.9k USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
183.3B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.7B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
42.3B USD
Loading...
Loading...
Loading...
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
298.3B CNY
Loading...
Loading...
Loading...
Loading...
US
United Therapeutics Corp
NASDAQ:UTHR
24.7B USD
Loading...
Loading...
Loading...
Loading...
DE
BioNTech SE
NASDAQ:BNTX
22.5B USD
Loading...
Loading...
Loading...
Loading...
BM
Roivant Sciences Ltd
NASDAQ:ROIV
19.7B USD
Loading...
Loading...
Loading...
Loading...
US
Moderna Inc
NASDAQ:MRNA
19.7B USD
Loading...
Loading...
Loading...
Loading...
US
Incyte Corp
NASDAQ:INCY
18.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Halberd Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett